Common variable immunodeficiency treated with a recombinant human IgG, tumour necrosis factor-α receptor fusion protein

British Journal of Dermatology

Volumn 144, Issue 3, 2001, Pages 597-600

  Smith, Kathleen J ^a,c   Skelton, H ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b LABORATORY CORPORATION OF AMERICA   (United States)

^c MC ^*  (United States)

Author keywords

Common variable immunodeficiency; Sarcoidal granulomas; Scarring alopecia; Tumour necrosis factor

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; ETANERCEPT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALOPECIA; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; COMMON VARIABLE IMMUNODEFICIENCY; GRANULOMATOUS INFLAMMATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; SCALP; SKIN BIOPSY;

ADULT; ALOPECIA; COMMON VARIABLE IMMUNODEFICIENCY; GRANULOMA; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035083652     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2001.04092.x     Document Type: Article

References (26)

1. Common variable immuno-deficiency: Clinical and immunologic features of 248 patients
2. Common variable immunodeficiency: How many diseases?
3. New insights into common variable immunodeficiency
4. Classification of patients with common variable immunodeficiency by B-cell secretion of IgM and IgG responses to anti-IgM and interleukin 2
5. Failure in antigen responses in common variable immunodeficiency (CVID) associated with failure in production of antigen-specific memory T cells
6. Interleukin 2 correction of defective in vitro T cell mitogenesis in patients with common variable immunodeficiency
7. Peripheral blood lymphocytes of patients with common variable immunodeficiency produce reduced levels of interleukin-4, interleukin-2, and interferon gamma, but proliferate normally upon activation with mitogens
8. Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency
9. The role of lymphokines in common variable hypogammaglobulinemia
10. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency: Possible immunologic and clinical consequences
11. Cutaneous granulomatous lesions in common variable immunodeficiency: Complete resolution after intravenous immunoglobulins
12. Caseating cutaneous granulomas in a child with common variable immunodeficiency
13. Cutaneous granulomas with two clinical presentations in a patient with common variable immunodeficiency
14. Sarcoidosis and common variable immunodeficiency: Report of 8 cases and review of the literature
15. Cutaneous sarcoid-like granulomas in primary immunodeficiency disorder
16. Characterization of common variable immunodeficiency: Identification of a subset of patients with distinctive immunophenotype and clinical features
17. Speculations on sarcoidosis
18. Detection of M. tuberculosis DNA in sarcoidosis: Correlation with T-cell response
19. In vivo modulation of cytokine synthesis by intravenous immunoglobulin
20. Biologic agents and immunotherapy in rheumatoid arthritis
21. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis
22. Update on sarcoidosis
23. Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: Analysis of the mechanism of action predicts utility in other disease
24. Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis
25. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial
26. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial